Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.6742
-$0.0458-6.36%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -60.75% | 142.43% | -10.03% | -48.40% | -48.76% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -19.81% | -3.54% | 18.63% | -30.74% | 357.49% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -57.39% | 115.61% | -5.85% | -46.41% | -43.05% |
|
|||||
Total Current Assets | -57.39% | 115.61% | -5.85% | -46.41% | -43.05% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | -- | -- |
Total Assets | -54.35% | 103.19% | -5.25% | -40.34% | -43.05% |
|
|||||
Total Accounts Payable | -24.87% | -28.42% | 87.02% | -17.95% | 48.62% |
Total Accrued Expenses | -17.37% | -10.74% | -4.11% | 6.64% | -37.63% |
Short-term Debt | -51.05% | 452.05% | -60.00% | -37.50% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -3.54% | 16.74% | -3.73% | 18.02% | -5.77% |
Total Other Current Liabilities | -3.54% | 16.74% | -3.73% | 18.02% | -5.77% |
Total Current Liabilities | -21.18% | -16.72% | 25.75% | -3.78% | -15.62% |
|
|||||
Total Current Liabilities | -21.18% | -16.72% | 25.75% | -3.78% | -15.62% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -51.05% | 452.05% | -60.00% | -37.50% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -68.76% | 14.25% | -48.14% | -57.15% | -56.55% |
Total Liabilities | -21.47% | -16.59% | 24.96% | -5.04% | -17.46% |
|
|||||
Common Stock & APIC | 0.70% | 11.52% | 3.08% | 2.25% | 0.26% |
Retained Earnings | -3.92% | -3.96% | -5.59% | -5.54% | -5.53% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -648.86% | 108.14% | -65.22% | -348.92% | -123.53% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -648.86% | 108.14% | -65.22% | -348.92% | -123.53% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -648.86% | 108.14% | -65.22% | -348.92% | -123.53% |
|